Institutional & Family Asset Management’s Emergent Biosolutions EBS Stock Holding History

Institutional & Family Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13	Closed	-$1K	–	960
2021 Q1	$1K	Sell	13 -7	-35%	-$717	﹤0.01%	858
2020 Q4	$2K	Sell	20 -1	-5%	-$92	﹤0.01%	756
2020 Q3	$2K	Buy	21 +10	+91%	+$1.08K	﹤0.01%	686
2020 Q2	$1K	Buy	+11	New	+$820	﹤0.01%	764
2019 Q1	–	Sell	-30	Closed	-$2K	–	849
2018 Q4	$2K	Hold	30	–	–	﹤0.01%	676
2018 Q3	$2K	Sell	30 -15	-33%	-$875	﹤0.01%	727
2018 Q2	$2K	Sell	45 -15	-25%	-$782	﹤0.01%	711
2018 Q1	$3K	Buy	+60	New	+$2.99K	﹤0.01%	656

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Institutional & Family Asset Management's EBS Position: Q2 2021 in Review

Institutional & Family Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 13 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in EBS in Q1 2018 and held it in 8 quarters. The position peaked at $3K in Q1 2018. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Institutional & Family Asset Management reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Institutional & Family Asset Management sold 13 Emergent Biosolutions shares in Q2 2021, an estimated $1K.
Institutional & Family Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 8 quarters.
Institutional & Family Asset Management's Emergent Biosolutions position peaked at $3K in Q1 2018.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Institutional & Family Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.